A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2014

At a glance

  • Drugs ARRY 403 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 08 Aug 2013 Results from this trial are now available and will be shared in the future, according to an Array BioPharma media release.
    • 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2012-001382-32).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top